Apricus Biosciences (APRI) Unit Receives FDA Clearance for Diphenhydramine-D
Tweet Send to a Friend
Apricus Biosciences, Inc. (Nasdaq: APRI) reports its wholly-owned subsidiary, NexMed USA, Inc., has received clearance from the U.S. Food and ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
